Jessica Nye, PhD

Research has shown that PLWH are at increased risk for cognitive disorders, including dementia. In addition, dementia is known to be a risk factor for COVID-19 mortality.

Any increase in ALT following treatment completion was found to be associated with treatment failure.

Carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa are a global threat to antimicrobial resistance and may be causative pathogens in cUTI.

Patients with HIV infection were randomly assigned to receive initial therapy with either B/F/TAF, dolutegravir (DTG)/abacavir/lamivudine, or DTG plus F/TAF for 144 weeks.

Patients hospitalized between 2017 and 2020 who were colonized with C. difficile were evaluated to determine the prevalence of hospital-onset CDI and its associated risk factors.

Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.

In this interim analysis, researchers evaluated patient data captured from year 4 of an extension study. The phase 3 trials were initiated in 2010 and completed in 2015, and the extension study was initiated in 2016; overall, the analysis comprised 10 years of data.

Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.

Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia (AN) and colorectal cancer (CRC).

Researchers sought to determine the prevalence of cardiovascular disease, cirrhosis, metabolic diseases, and chronic kidney disease in lean vs overweight or obese NAFLD.